Company / Income Tax
CytomX Therapeutics, Inc. Income Tax History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$238.0K
FY2025
5-year range
$0 / $3.9M
FY2021-FY2025
Trend
+6.3%
vs FY2024
Sector context
#96 of 204
Health Care
What the data says
At $238,000, CytomX Therapeutics, Inc.'s income tax ranks #109 of 204 in the Health Care sector. Income Tax has fluctuated over the past 10 years, ranging from -$14M in FY2020 to $14M in FY2018.
Based on SEC 10-K filings.
$238,000 in FY2025.
Improved from $4M to $238,000 over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#109 of 204 in Health CareTop 53% of 204This company $238.0K Sector average $118.7M
▼
-99.8% below sector average
Key checks
Key Insights
- In FY2025, income tax increased 6.3% year-over-year.
- Ranks #96 out of 204 companies in the Health Care sector.
- Peak income tax was recorded in FY2018.
- Lowest income tax in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -2.68 (distress zone, below 1.8 threshold)
- Strong profit margin: 23.1%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $238.0K | +6.3% |
| FY2024 | $224.0K | -94.2% |
| FY2023 | $3.9M | - |
| FY2022 | $0 | - |
| FY2021 | $0 | +100.0% |
| FY2020 | -$13.9M | -3157.8% |
| FY2019 | -$427.0K | -103.0% |
| FY2018 | $14.3M | +2888.1% |
| FY2017 | -$513.0K | -2600.0% |
| FY2016 | -$19.0K | -290.0% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026